Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visual and Anatomic Outcomes of Intravitreal Anti-VEGF Therapy for Exudative Age-related Macular Degeneration With Concurrent Significant Epiretinal Membrane.

NCT01846351 is registered in ClinicalTrials.gov with New England Retina Associates as lead sponsor.

NCT NCT01846351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01846351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visual and Anatomic Outcomes of Intravitreal Anti-VEGF Therapy for Exudative Age-related Macular Degeneration With Concurrent Significant Epiretinal Membrane.
Lead sponsor
New England Retina Associates
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
February 28, 2010
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, epiretinal membrane